Cleared Traditional

K240885 - Shadow Catheter

K240885 is an FDA 510(k) clearance for Shadow Catheter, manufactured by Simpson Interventions, Inc.. The device is a Class 2 Cardiovascular device with product code DQY cleared through the Traditional 510(k) pathway after a 262-day FDA review.

K240885 · Simpson Interventions, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2024
Decision
262d
Days
Class 2
Risk

K240885 is an FDA 510(k) clearance for the Shadow Catheter. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Simpson Interventions, Inc. (Campbell, US). The FDA issued a Cleared decision on December 19, 2024 after a review of 262 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Simpson Interventions, Inc. devices

FDA 510(k) Submission Details - K240885

510(k) Number K240885 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 01, 2024
Decision Date December 19, 2024
Days to Decision 262 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
137d slower than avg
Panel avg: 125d · This submission: 262d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQY Device Classification - Class 2, Special Controls

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 621
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K240885.
COREPASS Modular Microcatheter (FLEX)
K242588 · OrbusNeich Medical (Shenzhen) Co., Ltd. · Jan 2025
MitraClip™ G5 Steerable Guide Catheter (SGC0801)
K243224 · Abbott Medical · Dec 2024
SENDERO MAX Delivery Catheter
K242644 · Okami Medical, Inc. · Dec 2024
SSPC NXT Delivery Catheter
K243180 · CenterPoint Systems, LLC · Dec 2024
CrossFAST™ Integrated Microcatheter Guide Extension System (CFM55)
K242276 · Vantis Vascular, Inc. · Sep 2024
Selectra 3D Lead Delivery System (443624-443629, 451789-451791)
K240787 · Biotronik, Inc. · Sep 2024